How do you decide if a fractional CRO is right for a Series A company when RevOps exists but no revenue leader?
PULSEKNOWLEDGE LIBRARY
At Series A, the decision to bring in a fractional CRO when RevOps exists but no revenue leader is a bet on whether the company needs a disciplined sales process more urgently than a cultural leader. The anchor here is the Series A dynamic: you have product-market fit signals, a board expecting repeatable growth, and a RevOps function that has likely been building dashboards and tooling without a strategic hand to interpret them. The fractional CRO works when the core problem is pipeline predictability and deal execution, not when the company needs a long-term culture shift or founder-coaching relationship.
CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

The Series A Buying Committee and Deal Dynamics
The buying committee at a Series A company is not a formal sales organization - it is a rotating cast of the founding team, the board observer, and often a lead investor who sits in on key deals. The typical deal size ranges from $20,000 to $80,000 in annual contract value for B2B SaaS, with occasional enterprise deals above $150,000 that come through founder relationships. Budget approval is a two-step process: the buyer has a line item for the category (often under "sales tools" or "revenue operations") but the fractional CRO engagement itself gets approved by the CEO with board visibility, because it is an operating expense that touches headcount planning. The buyer evaluates three things: whether the fractional CRO has scaled a company from $2M to $10M ARR before, whether they can speak the language of the specific vertical (e.g., fintech, cybersecurity, vertical SaaS), and whether they will actually be available for weekly pipeline reviews versus just monthly board slides. Deals stall at Series A when the fractional CRO cannot articulate a clear transition plan - the buyer (CEO) fears that bringing in a part-time leader will create a dependency that delays hiring a full-time VP of Sales. The stalling happens at the "what happens in six months" question, not at the price point.
The Sales Cycle Motion a Fractional CRO Forces at Series A
The sales cycle for the fractional CRO engagement itself is short - typically two to three weeks from first conversation to start date - because the need is acute. But the motion this situation forces is a brutal triage: RevOps has been running reports on conversion rates, stage velocity, and rep activity, but without a revenue leader, those reports have no owner who can turn them into coaching actions. The fractional CRO arrives and immediately confronts a pipeline that is shaped like a hockey stick - 80% of expected revenue sits in the last two weeks of the quarter, because reps have been self-qualifying and founders have been closing deals personally without a standard process. Ramp for the fractional CRO is not about learning the product - it is about learning which deals are real versus which are founder-optimism. The forecast behavior in the first four weeks will be erratic: the fractional CRO will likely cut the pipeline by 40% to 60% because they apply rigorous qualification criteria (BANT, MEDDIC, or a custom scorecard) that the founder and RevOps never enforced. The leaks are concentrated in two places: the transition from SQL to demo (where reps skip discovery because they are used to founder-led demos that assume buyer knowledge) and the negotiation stage (where reps have no authority to discount and escalate every pricing question to the CEO). The fractional CRO's first action is to build a deal desk process that forces a weekly review of every deal above $30,000, with RevOps providing the data and the fractional CRO providing the judgment.

What a Fractional CRO Looks Like in the First 90 Days at Series A
The first 90 days are not about strategy - they are about surgical intervention. In week one, the fractional CRO audits every open deal with a live conversation, not a CRM report. They identify the top three deals that will close in the quarter and personally coach the reps on those. By week two, they establish a weekly pipeline review cadence that includes the CEO, the head of RevOps, and the top two reps, where every deal over $25,000 gets a score from 0 to 100 based on qualification criteria. The operating cadence is not a 40-hour week - it is a 15-hour week of high-leverage activities: two hours of deal coaching, two hours of pipeline review, two hours of working with RevOps to fix the most broken metric (usually lead-to-opportunity conversion rate), and the rest on ad-hoc calls with the CEO about hiring plans and board updates. The fractional CRO owns the sales process and the forecast, but they advise on everything else - pricing, packaging, channel partnerships, customer success handoff. The key distinction at Series A is that the fractional CRO must be willing to get into the weeds on individual deals because there are only 10 to 20 active opportunities at any time. They cannot be a pure strategist. The signals to convert to full-time are not revenue milestones - they are organizational signals: when the CEO starts asking "how do we hire a second-line manager?" or when the fractional CRO has to spend more than 20 hours a week because the deal volume has grown beyond what a part-time leader can manage. The conversion trigger is usually when the company hits 10 to 15 reps and the fractional CRO is spending more time on hiring and culture than on deal coaching. If the fractional CRO is still spending most of their time on individual deals after six months, the company is not ready for a full-time leader - it needs to hire a sales manager first.
The RevOps Dynamic: Why No Revenue Leader Exists
At Series A, RevOps exists because the company raised money and needed to look professional, or because the founder hired a data-savvy operator to build the CRM and reporting infrastructure. But RevOps without a revenue leader creates a vacuum: the RevOps person builds dashboards showing that the sales cycle is 90 days and the win rate is 25%, but no one in the company has the authority to change the behavior that produces those numbers. The fractional CRO fills this gap by becoming the decision-maker for process changes that RevOps recommends but cannot implement. For example, RevOps may have identified that the demo-to-close stage has a 60% drop-off, but without a revenue leader, no one can mandate a new demo script or force reps to do discovery calls. The fractional CRO becomes the executive sponsor for RevOps initiatives, which is a different relationship than a full-time CRO who might hire their own RevOps leader. The dynamic works well when the RevOps person is hungry for strategic direction and frustrated with being a report-builder. It fails when the RevOps person sees the fractional CRO as a threat to their career path. The fractional CRO must explicitly define the operating model: RevOps owns the data and the tooling, the fractional CRO owns the decisions and the coaching, and the CEO owns the budget and the headcount plan.

The Financial Calculus of Fractional vs. Full-Time at Series A
The financial decision is not about salary - it is about burn rate and optionality. A full-time VP of Sales at Series A costs $200,000 to $300,000 in base salary plus equity, with a total cash compensation of $350,000 to $500,000 when you include commissions and bonuses. A fractional CRO at this stage costs $8,000 to $15,000 per month for 10 to 20 hours per week, which is $96,000 to $180,000 annually. The fractional model saves $150,000 to $300,000 in cash, which at Series A is often the difference between extending runway by two to three months or hitting a down round. But the real calculus is opportunity cost: a full-time VP of Sales will spend their first 90 days hiring, ramping, and building culture, while a fractional CRO can focus on closing the next three to five deals that determine whether the company hits its Q2 board target. The fractional CRO is a bridge, not a destination. The board will evaluate the decision based on whether the company needs a "builder" (full-time) or a "fixer" (fractional). At Series A, the answer is almost always a fixer first, because the company has not yet proven it can scale sales without the founder. The exception is when the founder has already hired a strong VP of Sales who left unexpectedly - then the fractional CRO is a stopgap, and the board will push for a full-time replacement within 60 days.
The Board and Investor Perspective on Fractional CROs at Series A
Investors at Series A are skeptical of fractional CROs for two reasons: they have seen them fail to create lasting process change, and they worry that the engagement signals the CEO is avoiding a hard hire. But the board will support a fractional CRO if the alternative is a full-time hire who takes three months to ramp and misses the quarter. The key is that the fractional CRO must have a clear mandate from the board, not just from the CEO. The board will ask three questions: (1) How does this person get integrated into the weekly board reporting? (2) What is the specific metric they are accountable for? (3) What is the off-ramp? The fractional CRO must present a board update in the first two weeks that shows the current pipeline reality - not the founder's optimistic forecast - and then commit to a specific number for the next quarter. The board will tolerate a lower forecast from a fractional CRO because they trust the rigor more than the founder's hope. The investor perspective is that a fractional CRO is a signal of maturity - it shows the CEO knows what they don't know. But it becomes a red flag if the fractional CRO is still there after nine months without a plan to hire full-time. The board will start asking "why can't we close a VP of Sales?" and the answer cannot be "we haven't looked." The fractional CRO must actively participate in the search for their own replacement, or the board will lose confidence in the CEO's judgment.
FAQ
A question? How do I know if my Series A company is ready for a fractional CRO versus just needing a sales manager?
You are ready for a fractional CRO when the problem is strategic - deals are stalling because there is no consistent qualification framework, the forecast is unreliable, and the founder is the only person who can close. You need a sales manager when the problem is tactical - reps are not hitting activity targets, the CRM is a mess, and you need someone to run daily stand-ups. A fractional CRO can diagnose which one you need in two weeks, but if you already know you just need a manager, hire a full-time sales director instead.
A question? What happens if the fractional CRO and RevOps person disagree on pipeline scoring?
That disagreement is a feature, not a bug. The fractional CRO should have the final say on deal scoring because they are the one accountable for the forecast. RevOps should challenge the scoring with data - for example, showing that deals the CRO scored as "80" have historically closed at a 30% rate. The resolution is a weekly scoring calibration meeting where both parties review the last 10 closed deals and adjust the criteria. If the disagreement persists after four weeks, the fractional CRO is likely being too optimistic, and the board should be told.
A question? How do I compensate a fractional CRO at Series A - should they get equity?
Fractional CROs at Series A typically get a flat monthly retainer with a performance bonus tied to quarterly revenue targets, not equity. Equity complicates the part-time relationship because of vesting schedules and 409A valuation issues. The bonus should be 20% to 30% of the retainer, paid quarterly if the company hits 80% of the forecast. Avoid giving stock options to a fractional CRO unless they are working 30+ hours a week and are expected to transition to full-time within six months.
A question? What is the biggest mistake Series A companies make when hiring a fractional CRO?
The biggest mistake is hiring a fractional CRO who has only worked at companies with $50M+ ARR. They will try to implement enterprise sales processes like MEDDIC and complex territory planning that overwhelm a 10-person sales team. The right fractional CRO for Series A has done the $2M-to-$10M transition at least twice, ideally in a similar industry. They should be able to articulate the specific three things they will change in the first 30 days - if they cannot name those three things in the first conversation, they are not the right fit.
Sources
- https://hbr.org/
- https://www.mckinsey.com/
- https://www.gartner.com/
- https://www.forrester.com/
- https://www.salesforce.com/resources/
Related on PULSE
- [How do you decide if a CRO advisory before a full-time hire is right for a Series A company when RevOps exists but no revenue leader?](/knowledge/q10570)
- [How do you decide if a fractional Chief Revenue Officer is right for a first enterprise motion company when RevOps exists but no revenue leader?](/knowledge/q10635)
- [How do you decide if a interim CRO is right for a first enterprise motion company when RevOps exists but no revenue leader?](/knowledge/q10634)
- [How do you decide if a fractional Chief Revenue Officer is right for a founder-led sales company when RevOps exists but no revenue leader?](/knowledge/q10625)
- [How do you decide if a interim CRO is right for a founder-led sales company when RevOps exists but no revenue leader?](/knowledge/q10624)
- [How do you decide if a full-time CRO is right for a PE-backed company when RevOps exists but no revenue leader?](/knowledge/q10607)









